h1

001008080 001__ 1008080
001008080 005__ 20251001135038.0
001008080 0247_ $$2HSB$$aeva591656
001008080 0247_ $$2ISSN$$a1664-3224
001008080 0247_ $$2SCOPUS$$aSCOPUS:2-s2.0-85213678932
001008080 0247_ $$2WOS$$aWOS:001385304700001
001008080 0247_ $$2doi$$a10.3389/fimmu.2024.1321336
001008080 0247_ $$2pmid$$apmid:39737169
001008080 0247_ $$2datacite_doi$$a10.18154/RWTH-CONV-254459
001008080 037__ $$aRWTH-CONV-254459
001008080 041__ $$aEnglish
001008080 1001_ $$0P:(DE-82)IDM06393$$aStiehl, Thomas Peter$$b0$$urwth
001008080 245__ $$aStem cell graft dose and composition could impact on the expansion of donor-derived clones after allogeneic hematopoietic stem cell transplantation – a virtual clinical trial$$honline
001008080 260__ $$aLausanne$$bFrontiers Media$$c2024
001008080 3367_ $$00$$2EndNote$$aJournal Article
001008080 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal
001008080 3367_ $$0PUB:(DE-HGF)7$$2PUB:(DE-HGF)$$aContribution to a book
001008080 3367_ $$2BibTeX$$aARTICLE
001008080 3367_ $$2DRIVER$$aarticle
001008080 3367_ $$2DataCite$$aOutput Types/Journal article
001008080 3367_ $$2ORCID$$aJOURNAL_ARTICLE
001008080 591__ $$aDenmark
001008080 591__ $$aGermany
001008080 770__ $$aImproving Stem Cell Transplantation Delivery Using Computational Modelling / Editors: Pawan Kumar Raghav, Vinay Randhawa, Eva Maria Weissinger
001008080 773__ $$0PERI:(DE-600)2606827-8$$a10.3389/fimmu.2024.1321336$$p1-22$$tFrontiers in immunology$$v15$$x1664-3224
001008080 8564_ $$uhttps://publications.rwth-aachen.de/record/1008080/files/1008080.pdf$$yOpenAccess
001008080 909CO $$ooai:publications.rwth-aachen.de:1008080$$popenaire$$popen_access$$pVDB$$pdriver$$pdnbdelivery
001008080 9101_ $$0I:(DE-588b)36225-6$$6P:(DE-82)IDM06393$$aRWTH Aachen$$b0$$kRWTH
001008080 9141_ $$y2024
001008080 9151_ $$0StatID:(DE-HGF)0031$$2StatID$$aPeer reviewed article$$x0
001008080 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection$$d2024-12-28
001008080 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline$$d2024-12-28
001008080 915__ $$0LIC:(DE-HGF)CCBY4$$2HGFVOC$$aCreative Commons Attribution CC BY 4.0
001008080 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bFRONT IMMUNOL : 2022$$d2024-12-28
001008080 915__ $$0StatID:(DE-HGF)0500$$2StatID$$aDBCoverage$$bDOAJ$$d2023-12-29T15:23:07Z
001008080 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS$$d2024-12-28
001008080 915__ $$0StatID:(DE-HGF)0501$$2StatID$$aDBCoverage$$bDOAJ Seal$$d2023-12-29T15:23:07Z
001008080 915__ $$0StatID:(DE-HGF)0113$$2StatID$$aWoS$$bScience Citation Index Expanded$$d2024-12-28
001008080 915__ $$0StatID:(DE-HGF)0700$$2StatID$$aFees$$d2024-12-28
001008080 915__ $$0StatID:(DE-HGF)0510$$2StatID$$aOpenAccess
001008080 915__ $$0StatID:(DE-HGF)0561$$2StatID$$aArticle Processing Charges$$d2024-12-28
001008080 915__ $$0StatID:(DE-HGF)9905$$2StatID$$aIF >= 5$$bFRONT IMMUNOL : 2022$$d2024-12-28
001008080 915__ $$0StatID:(DE-HGF)0160$$2StatID$$aDBCoverage$$bEssential Science Indicators$$d2024-12-28
001008080 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List$$d2024-12-28
001008080 9201_ $$0I:(DE-82)929420_20210202$$k929420$$lInstitut und Lehr- und Forschungsgebiet Disease Modelling mit Schwerpunkt auf Phasenübergängen zwischen Phänotypen$$x0
001008080 961__ $$z2025-03-20
001008080 970__ $$aeva591656
001008080 9801_ $$aFullTexts
001008080 980__ $$aI:(DE-82)929420_20210202
001008080 980__ $$aUNRESTRICTED
001008080 980__ $$aVDB
001008080 980__ $$acontb
001008080 980__ $$ajournal